Can a multi-stakeholder prioritisation structure support regulatory decision making? A review of paediatric oncology strategy forums reflecting on challenges and opportunities of this concept.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical pharmacology and therapeutics"
DOI: 10.1002/cpt.1939
Abstract: Timely and successful drug development for rare cancer populations, such as paediatric oncology requires consolidated efforts in the spirit of shared responsibility. In order to advance tailored development efforts, the concept of multi-stakeholder Strategy Forum… read more here.
Keywords: strategy forums; oncology strategy; multi stakeholder; paediatric oncology ... See more keywords